Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Remote Monitoring Consolidation Continues As Connect America Acquires 100Plus

Executive Summary

Connect America plans to combine its Personal Emergency Response Services with 100Plus' patient-friendly remote patient monitoring solutions to offer a single care-management platform to payers who care for at-risk populations.

You may also be interested in...



Cardiovascular Catch-Up: Philips New AI Finds AF Needle In ECG Haystack; LimFlow Moves Closer To US Approval

Medtech Insight’s Cardiovascular Catch-Up highlights recent news and insights from cardiovascular device companies – big and small. Part two of this month's installment includes updates from lesser-known companies that you might have missed, including Cardiologs, Rhythm Management, LimFlow and ShockWave.

Minute Insight: Philips Continues Building Monitoring Business By Acquiring Cardiologs

Paris-based Cardiologs is developing machine learning software to analyze electrocardiogram waveforms to detect arrhythmias.

Biden Admin Looks To Broaden Telehealth, Increase Access To Mental Health Care

Proposals from the US Centers for Medicare & Medicaid Services (CMS) would help make telehealth a permanent fixture across the healthcare landscape, particularly for treating mental health.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT144386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel